Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Gross Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed Gross Margin for 11 consecutive years, with 91.86% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin fell 12719.0% to 91.86% in Q3 2025 year-over-year; TTM through Sep 2025 was 66.61%, a 681.0% decrease, with the full-year FY2024 number at 83.27%, up 414.0% from a year prior.
  • Gross Margin was 91.86% for Q3 2025 at Jaguar Health, down from 82.31% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 225.74% in Q4 2023 to a low of 10966.67% in Q2 2021.
  • A 5-year average of 719.37% and a median of 72.16% in 2021 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: crashed -1103411bps in 2021, then surged 1105106bps in 2022.
  • Jaguar Health's Gross Margin stood at 237.98% in 2021, then surged by 48bps to 123.16% in 2022, then surged by 283bps to 225.74% in 2023, then fell by -18bps to 186.12% in 2024, then tumbled by -149bps to 91.86% in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Gross Margin are 91.86% (Q3 2025), 82.31% (Q2 2025), and 76.74% (Q1 2025).